Document Detail

Surgical treatment of age-related macular degeneration: will there be a role in the future?
MedLine Citation:
PMID:  17362461     Owner:  NLM     Status:  MEDLINE    
Surgical treatment has been shown to be able to improve vision that is lost as a result of age-related macular degeneration. Surgery is complex, such that improvement has always to be weighed against risk of complications. The availability of Ranibizumab and Bevacizumab is set to dramatically alter our management options. Surgical treatment will have a limited role to play in the next few years.
David Wong; Jon M Durnian
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Clinical & experimental ophthalmology     Volume:  35     ISSN:  1442-6404     ISO Abbreviation:  Clin. Experiment. Ophthalmol.     Publication Date:  2007 Mar 
Date Detail:
Created Date:  2007-03-16     Completed Date:  2007-05-15     Revised Date:  2013-05-27    
Medline Journal Info:
Nlm Unique ID:  100896531     Medline TA:  Clin Experiment Ophthalmol     Country:  Australia    
Other Details:
Languages:  eng     Pagination:  167-73     Citation Subset:  IM    
University of Hong Kong, Li Ka Shing Faculty of Medicine, Pok Fu Lam, Hong Kong, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antibodies, Monoclonal / therapeutic use
Antibodies, Monoclonal, Humanized
Cost of Illness
Macular Degeneration / economics,  etiology,  surgery*
Ophthalmologic Surgical Procedures / trends*
Vascular Endothelial Growth Factor A / antagonists & inhibitors
Reg. No./Substance:
0/Antibodies, Monoclonal; 0/Antibodies, Monoclonal, Humanized; 0/VEGFA protein, human; 0/Vascular Endothelial Growth Factor A; 0/ranibizumab; 2S9ZZM9Q9V/bevacizumab

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Granulation tissue in the eyelid margin and conjunctiva in junctional epidermolysis bullosa with fea...
Next Document:  Periocular squamous cell carcinoma.